Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Analgesics & rebound headache

This article was originally published in The Tan Sheet

Executive Summary

Chronic use of OTC analgesics that can lead to "rebound headache" may be situation "where we need to improve the labeling and get better information out to consumers so that they can avoid the problem," FDA Commissioner Mark McClellan, MD/PhD, suggests during Jan. 15 appearance on National Public Radio's Diane Rehm Show. If consumers "are using the product very frequently for headaches, they probably should contact their health professional to see if there is another cause for the recurrent headaches, or if there is a better treatment available," he adds. McClellan's comments were prompted by article suggesting link between rebound headache and analgesic use in the Jan. 12 New York Times. Segment on the issue also aired on ABC TV's 20/20 program Jan. 10...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095015

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel